<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02161874</url>
  </required_header>
  <id_info>
    <org_study_id>3023</org_study_id>
    <nct_id>NCT02161874</nct_id>
  </id_info>
  <brief_title>Evaluation of Integration Success and Crestal Bone Preservation Biomet 3i's T3 Implant System</brief_title>
  <acronym>OAK</acronym>
  <official_title>A Prospective, Randomized-controlled Evaluation of Biomet 3i's T3 Implant System for Integration Success and the Preservation of Crestal Bone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the T3 implant system for the preservation of alveolar crestal bone and
      the establishment of initial integration. The new surface-treated features of the implant may
      contribute to improved soft and hard tissue healing. The success rate of the T3 implant will
      be no different than that of the control implant, which possess similar geometry but
      different surface treatments.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective, randomized-controlled study will enroll qualified patients with partial
      edentulism who will be treated with at least two dental implants. Implant sites will be
      randomly assigned to receive either a test (T3 implant) or control (Nanotite Certain Tapered
      implant) with an 80:20 (test:control) randomization ratio.

      All implants will be allowed to integrate without occlusal forces and final restorations will
      be cemented thereafter.

      Cumulative success rate and crestal bone regression of both treatment groups will be the
      primary and secondary study endpoints, respectively.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative success rate</measure>
    <time_frame>1 year</time_frame>
    <description>Implant mobility is assessed by clinical evaluations and correlation to initial placement stability- insertion torque profiles.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Crestal bone changes</measure>
    <time_frame>2 years</time_frame>
    <description>Crestal bone regression (amount of bone loss) between the two treatment groups will be compared</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Partial Edentulism</condition>
  <condition>Tooth Disease</condition>
  <arm_group>
    <arm_group_label>T3 with DCD tapered implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>T3 with DCD tapered prevail implant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nanotite certain tapered implant</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nanotite Certain tapered implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>T3 with DCD tapered Prevail implant</intervention_name>
    <description>T3 with DCD implant with Certain (internal) connection and platform-switch design</description>
    <arm_group_label>T3 with DCD tapered implant</arm_group_label>
    <other_name>T3 with Nanotite</other_name>
    <other_name>T3 with platform switch</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nanotite Certain tapered implant</intervention_name>
    <description>Nanotite (DCD) implant with Certain (internal) connection and non- platform-switch design</description>
    <arm_group_label>Nanotite certain tapered implant</arm_group_label>
    <other_name>Nanotite tapered certain</other_name>
    <other_name>Non-platform switched</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of either sex and any race greater than 18 years of age

          -  Patients for whom a decision has already been made to use dental implants for the
             restoration of existing edentulism in the mandible or maxilla.

          -  Patients must be physically able to tolerate conventional surgical and restorative
             procedures.

          -  Patients must agree to be evaluated for each study visit, especially the yearly
             follow-up visits

        Exclusion Criteria:

          -  Patients with active infection or severe inflammation in the areas intended for
             implant placement.

          -  Patients with a &gt; 10 cigarette per day smoking habit.

          -  Patients with uncontrolled diabetes mellitus.

          -  Patients with uncontrolled metabolic bone disease where there is a diagnosis of the
             following: Osteomalacia, primary or secondary hyperparathyroidism, renal
             osteodystrophy, or Paget's disease of bone.

          -  Patients with a history of therapeutic radiation to the head

          -  Patients in need of bone grafting at the site of the intended study implant for
             augmentation purposes.

          -  Patients who are known to be pregnant at the screening visit.

          -  Patients with evidence of severe para-functional habits such as bruxing or clenching.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicholas Lewis, DMD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eastman Dental Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dr. Tommie VanDeVelde</name>
      <address>
        <city>Antwerp</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Dominique Caspar</name>
      <address>
        <city>Les Bains</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Felix Hanssler</name>
      <address>
        <city>Goppingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Nicholas Lewis</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2014</study_first_submitted>
  <study_first_submitted_qc>June 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2014</study_first_posted>
  <last_update_submitted>March 20, 2017</last_update_submitted>
  <last_update_submitted_qc>March 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>edentulism</keyword>
  <keyword>dental implants</keyword>
  <keyword>clinical study</keyword>
  <keyword>endosseous</keyword>
  <keyword>randomized</keyword>
  <keyword>crestal bone level</keyword>
  <keyword>T3</keyword>
  <keyword>Nanotite Certain</keyword>
  <keyword>Nanotite Certain Prevail</keyword>
  <keyword>Tapered</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tooth Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

